Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. It operates through three segments: Analytical, Animal Health and Life Sciences. The Analytical segment provides tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health segment provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Life Sciences segment provides reagents and arrays for diagnostics, drug and biomarker discovery in biotech research and development. Its subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited and others.
Show more
Type
Public
HQ
Thorp Arch Estate, GB
Founded
2003
Size (employees)
87 (est)
Website
avacta.com
Avacta Group was founded in 2003 and is headquartered in Thorp Arch Estate, GB
Report incorrect company information

Key People/Management at Avacta Group

Alastair Smith

Alastair Smith

Chief Executive Officer
Tony Gardiner

Tony Gardiner

Chief Financial Officer
Matt Johnson

Matt Johnson

Chief Technology Officer
Amrik Basran

Amrik Basran

Chief Scientific Officer
Mike Owen

Mike Owen

Senior Independent Director & Scientific Advisory Board Chairman
Alan Aubrey

Alan Aubrey

Non Executive Director
Show more

Avacta Group Office Locations

Avacta Group has offices in London and Thorp Arch Estate
Thorp Arch Estate, GB (HQ)
706 Avenue E West
London, GB
200 Aldersgate St
Show all (2)
Report incorrect company information

Avacta Group Financials and Metrics

Avacta Group Financials

Avacta Group's revenue was reported to be £1.28 m in FY, 2017
GBP

Revenue (FY, 2017)

1.3 m

Gross profit (FY, 2017)

859.4 k

Gross profit margin (FY, 2017), %

67%

Net income (FY, 2017)

(6.6 m)

EBITDA (FY, 2017)

(6.9 m)

EBIT (FY, 2017)

(7.9 m)

Market capitalization (31-Oct-2017)

45.5 m

Closing share price (31-Oct-2017)

0.7

Cash (31-Jul-2017)

115.9 k
Avacta Group's current market capitalization is £45.5 m.
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

8.7 k29.8 k171.5 k866.8 k1.3 m

Revenue growth, %

475%405%

Cost of goods sold

4 k10.5 k77 k451.1 k422.5 k

Gross profit

4.7 k19.3 k94.5 k415.6 k859.4 k
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

32.8 k298.3 k113.4 k40 k23.7 k385.9 k246.4 k96.3 k115.9 k

Accounts Receivable

2.4 k5.8 k12 k61.1 k45.3 k81.3 k

Inventories

173.4 k274.8 k215.4 k72.7 k

Current Assets

35.2 k304.2 k118.1 k100.3 k214.1 k1 m1.7 m2.4 m2.3 m
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(388.1 k)(977.4 k)(2.3 m)(4.9 m)(6 m)(6.6 m)

Income Taxes Paid

310.5 k370.5 k1 m
GBPY, 2017

Revenue/Employee

14.7 k

Financial Leverage

-0.3 x
Show all financial metrics
Report incorrect company information

Avacta Group News and Updates

Avacta Group Plc (AVCT) Market Clinical Trials Review, H2, 2017 Strategies 2017 by Analyzing the Performance of Various Competitors

WiseGuyReports published new report, titled “Avacta Group Plc (AVCT)” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information